Etoposide damages female germ cells in the developing ovary

BACKGROUND: As with many anti-cancer drugs, the topoisomerase II inhibitor etoposide is considered safe for administration to women in the second and third trimesters of pregnancy, but assessment of effects on the developing fetus have been limited. The purpose of this research was to examine the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefansdottir, Agnes, Johnston, Zoe C., Powles-Glover, Nicola, Anderson, Richard A., Adams, Ian R., Spears, Norah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980800/
https://www.ncbi.nlm.nih.gov/pubmed/27510889
http://dx.doi.org/10.1186/s12885-016-2505-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980800/
https://www.ncbi.nlm.nih.gov/pubmed/27510889
http://dx.doi.org/10.1186/s12885-016-2505-9

Ejemplares similares